Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Total 13F shares
-
21,550,279
-
Share change
-
+6,176,497
-
Total reported value
-
$1,311,636,981
-
Put/Call ratio
-
58%
-
Price per share
-
$60.87
-
Number of holders
-
98
-
Value change
-
+$387,558,387
-
Number of buys
-
60
-
Number of sells
-
35
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q4 2021
As of 31 Dec 2021,
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,550,279 shares.
The largest 10 holders included
Ridgeback Capital Investments L.P., TYBOURNE CAPITAL MANAGEMENT (HK) LTD, JANUS HENDERSON GROUP PLC, Point72 Asset Management, L.P., FMR LLC, EVENTIDE ASSET MANAGEMENT, LLC, Deep Track Capital, LP, First Light Asset Management, LLC, SV Health Investors, LLC, and Logos Global Management LP.
This page lists
98
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.